![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Issue contents]](/e/graphics/issuecontentsborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](nc2071contents.gif)
Acta Cryst. (2007). E63, m2965 [ doi:10.1107/S1600536807055274 ]
![[mu]](/logos/entities/mu_rmgif.gif)
-4-carboxybenzene-1,2-dicarboxylato)-1:2![[kappa]](/logos/entities/kappa_rmgif.gif)
3O3,O4:O3;1:23O3:O3,O4-bis[1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(piperazin-1-yl)quinoline-3-carboxylato-2O,O']dizinc(II) hexahydrateAbstract: In the crystal structure of the title compound, [Zn2(C16H18FN3O3)2(C9H4O6)2]·6H2O, the ZnII atoms are each coordinated by five O atoms within a distorted trigonal biyramid. The two ZnII atoms are connected by two symmetry-related carboxylate O atoms into dimers, which are located on centres of inversion. These dimers are linked by N-H
O and O-HO hydrogen bonding.
Online 9 November 2007
Copyright © International Union of Crystallography
IUCr Webmaster